TransThera Wins Approval to Convert 44,971,128 Unlisted Shares Into H Shares

• TransThera Sciences (Nanjing) secured Hong Kong Stock Exchange clearance on October 30, 2026, to convert 44,971,128 unlisted shares into H shares.
• The conversion covers holdings of 10 shareholders, representing 11.01% of issued share capital.
• H shares will rise to 358,318,801, or 87.7% of total shares, upon completion.
• Unlisted shares will fall to 50,259,832, or 12.3%; total issued shares will remain unchanged at 408,578,633.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences (Nanjing) Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261101-12391757), on November 01, 2026, and is solely responsible for the information contained therein.